NBI-27914 is a potent and selective antagonist of CRFR1. The CRF receptors, CRFR1 and CRFR2, are members of the G protein-coupled receptor superfamily.
Die Produkte sind ausschließlich für Forschungszwecke bestimmt. Nicht zur Anwendung am Menschen. Wir verkaufen nicht an Patienten.
| Pack Size | Price | Availability | Quantity | Action |
|---|---|---|---|---|
| 1mg | $51.00 | In Stock | 1 | |
| 5mg | $113.00 | In Stock | 1 | |
| 10mg | $180.00 | In Stock | 1 | |
| 25mg | $378.00 | In Stock | 1 |
NBI-27914 is a potent and selective antagonist of CRFR1. The CRF receptors, CRFR1 and CRFR2, are members of the G protein-coupled receptor superfamily[1].
References:
[1]. Liaw CW, et al. Localization of agonist- and antagonist-binding domains of human corticotropin-releasing factor receptors. Mol Endocrinol. 1997;11(13):2048-2053.